SCHEMBL21784889

SCHEMBL21784889

c1ccc(-c2nc(-c3ccc4oc5cc6c(cc5c4c3)oc3ccccc36)nc(-c3ccccc3-c3ccccc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.41
ALDH1A1 P00352 7/20 0.41
HPGD P15428 5/20 0.41
KDM4E B2RXH2 5/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
AHR P35869 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHEK2 O96017 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
PLA2G2A P14555 3/20 0.39
PLA2G4A P47712 3/20 0.39
GPR55 Q9Y2T6 1/20 0.39
POLB P06746 1/20 0.38
PLA2G10 O15496 1/20 0.37
ALOX15 P16050 2/20 0.37
TSHR P16473 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21784662 0.99 PLA2G2A (0.41) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL24318110 0.97 PLA2G2A (0.43) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL24318020 0.97 PLA2G2A (0.43) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL24318026 0.97 PLA2G2A (0.43) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL24318045 0.97 PLA2G2A (0.43) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL21784664 0.96 PLA2G2A (0.43) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL24318027 0.96 PLA2G2A (0.43) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL21784663 0.95 PLA2G2A (0.42) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL21563807 0.94 MAPT (0.42) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL23268360 0.94 MAPT (0.45) MAPTALDH1A1HPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 US disclosed
WO-2020044270-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2020-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 MAPT 3163/4885ALDH1A1 718/4885HPGD 1975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.